KRRO-121

N/A

Report date: 2026/04/13 20:02:18

NME

Base Information

Drug NameKRRO-121

Drug Alias NameRNA-editing oligonucleotide conjugated with GalNAc KRRO-121KRRO-121KRRO121

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideCell and gene therapy > Gene therapy > Gene editing > RNA editing

Mechanisms of ActionGlutamine Synthetase agonists

TargetsGlutamine Synthetase

Therapy Area/IndicationsUrea Cycle Disorders, InbornHepatic Encephalopathy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKorro Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesKorro Bio Inc

Inactive CompaniesN/A

Active IndicationsUrea Cycle Disorders, InbornHepatic Encephalopathy

Inactive IndicationsN/A

Other Information

ATC CodeN/A